Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international b.v. - fluralaner, moxidectin - antiparasitic products, insecticides and repellents, endectocides, milbemycins - cats - for cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. the veterinary medicinal product is exclusively indicated when use against ticks or fleas and one or more of the other target parasites is indicated at the same time.for the treatment of tick and flea infestations in cats providing immediate and persistent flea (ctenocephalides felis) and tick (ixodes ricinus) killing activity for 12 weeks. fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for flea allergy dermatitis (fad).for the treatment of infestations with ear mites (otodectes cynotis).for the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of toxocara cati) and hookworm (4th stage larvae, immature adults and adults of ancylostoma tubaeforme).when administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by dirofilaria immitis

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - bluetongue virus vaccine, serotype 8 (inactivated) - inactivated viral vaccines, bluetongue virus, sheep - sheep; cattle - cattle to stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia sheep to stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia,

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international b.v. - inactivated leptospira strains: l. interrogans serogroup canicola serovar portland-vere (strain ca-12-000); l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); l. interrogans serogroup australis serovar bratislava (strain as-05-073); l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals for canidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - dogs - for active immunisation of dogs against:l. interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal/lianguang to reduce infection and urinary excretion.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - equine influenza-virus strains: a/equine-2/south africa/4/03, a/equine-2/newmarket/2/93 - equine influenza virus - horses - active immunisation of horses from six months of age against equine influenza to reduce clinical signs and virus excretion after infection.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - live deletion-mutant streptococcus equi strain tw928 - immunologicals for equidae - horses - for immunisation of horses against streptococcus equi to reduce clinical signs and occurrence of lymph-node abscesses.onset of immunity: the onset of immunity is established as two weeks after basic vaccination.duration of immunity: the duration of immunity is up to three months.the vaccine is intended for use in horses for which a risk of streptococcus equi infection has been clearly identified, due to contact with horses from areas where this pathogen is known to be present, e.g. stables with horses that travel to shows or competitions in such areas, or stables that obtain or have livery horses from such areas.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - inactivated chimaeric flavivirus strain yf-wn - immunologicals - horses - active immunisation of horses against west nile virus (wnv) to reduce clinical signs of disease and lesions in the brain and to reduce viraemia. onset of immunity: 2 weeks after primary vaccination course of two injections. duration of immunity: 12 months.,

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - estriol - sex hormones and modulators of the genital system - dogs - the treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ilt-138), expressing the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals for aves, live viral vaccines - chicken - for active immunisation of one-day-old chicks to reduce mortality, clinical signs and lesions due to infection with avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international bv - live attenuated avian infectious bronchitis virus variant strain 4-91 - immunologicals for aves - chicken - active immunisation of chickens to reduce the respiratory signs of infectious bronchitis caused by the variant strain ib 4-91.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

intervet international b.v. - live avian infectious bronchitis virus, strain d388 - live viral vaccines, domestic fowl - chicken - for active immunisation of chickens in order to reduce respiratory signs of avian infectious bronchitis caused by qx-like variants of infectious bronchitis virus.